ReviewCurrent pharmaceutical design2024

Cellular and Mitochondrial Pathways Contribute to SGLT2 Inhibitors-mediated Tissue Protection: Experimental and Clinical Data.

Raúl Lelio Sanz et al.PubMed ↗Publisher ↗

No numbers read from the abstract.